TherapeuticsMD Stock Forecast for 2023 - 2025 - 2030

Updated on 04/26/2024

Stock Rating
5
Price Target
$2.33
Consensus
-
Upside
3.10%
Analysts
0
Stock Rating
5
Upside
3.10%
Analysts
0
Price Target
$2.33

TherapeuticsMD Stock Forecast and Price Target

The average target price set lately by experts for TherapeuticsMD to reach by the end of the year is $2.33, which would imply a potential upside of approximately 3.1 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $2.60 and a low estimate of $2.07. If you want to buy TXMD stock, it might be a good idea to look at its competitors too.

$2.33

3.10% Upside

-

TherapeuticsMD Fair Value Forecast for 2023 - 2025 - 2030

In the last zero years, TherapeuticsMD's Price has grown by 100.00%, rising from $0.00 to $0.00. For next year, analysts predict Fair Value of $2.25, which would mean an increase of 100.00%. Over the next twelve years, experts predict that TherapeuticsMD's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$2.25
2025 Fair Value Forecast
$2.40
2025 Fair Value Forecast
$2.40
2026 Fair Value Forecast
$2.55
2027 Fair Value Forecast
$2.85
2027 Fair Value Forecast
$2.85
2028 Fair Value Forecast
$3.00
2028 Fair Value Forecast
$3.00
2029 Fair Value Forecast
$3.30
2029 Fair Value Forecast
$3.30
2030 Fair Value Forecast
$3.45
2030 Fair Value Forecast
$3.45
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
NOVO B Stock Forecast Novo Nordisk A/S Outperform 12
kr866.80 Buy/Sell kr696.07 10.75%
MRK Stock Forecast Merck Outperform 2
$130.72 Buy/Sell $130.51 7.10%
ABBV Stock Forecast AbbVie Outperform 9
$167.29 Buy/Sell $178.42 12.98%
PFE Stock Forecast Pfizer Outperform 2
$25.26 Buy/Sell $32.87 20.74%
BAYN Stock Forecast Bayer Hold 5
26.90€ Buy/Sell 45.15€ 11.52%

TherapeuticsMD Revenue Forecast for 2023 - 2025 - 2030

2024 Rev Forecast
$0.01B
2025 Rev Forecast
$0.01B
2026 Rev Forecast
$0.01B
2026 Rev Forecast
$0.01B
2027 Rev Forecast
$0.01B
2028 Rev Forecast
$0.01B
2029 Rev Forecast
$0.01B
2029 Rev Forecast
$0.01B
2030 Rev Forecast
$0.01B
2030 Rev Forecast
$0.01B

TherapeuticsMD Dividend per Share Forecast for 2023 - 2025 - 2030

TherapeuticsMD Free Cash Flow Forecast for 2023 - 2025 - 2030

2025 FCF Forecast
$0.00B
2026 FCF Forecast
$0.00B
2026 FCF Forecast
$0.00B
2027 FCF Forecast
$0.00B
2028 FCF Forecast
$0.00B
2028 FCF Forecast
$0.00B
2029 FCF Forecast
$0.00B
2029 FCF Forecast
$0.00B
2030 FCF Forecast
$0.00B
2030 FCF Forecast
$0.00B

TherapeuticsMD EBITDA Forecast for 2023 - 2025 - 2030

TherapeuticsMD EBIT Forecast for 2023 - 2025 - 2030

2024 EBIT Forecast
$0.00B
2024 EBIT Forecast
$0.00B
2025 EBIT Forecast
$0.00B
2025 EBIT Forecast
$0.00B
2026 EBIT Forecast
$0.00B
2026 EBIT Forecast
$0.00B
2027 EBIT Forecast
$0.00B
2028 EBIT Forecast
$0.00B
2029 EBIT Forecast
$0.00B
2030 EBIT Forecast
$0.00B

TherapeuticsMD EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last zero years, TherapeuticsMD's EPS has grown by 100.00%, rising from $0.00 to $0.00. For next year, analysts predict EPS of $0.15, which would mean an increase of 100.00%. Over the next twelve years, experts predict that TherapeuticsMD's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$0.15
2025 EPS Forecast
$0.16
2025 EPS Forecast
$0.16
2026 EPS Forecast
$0.17
2027 EPS Forecast
$0.19
2027 EPS Forecast
$0.19
2028 EPS Forecast
$0.20
2028 EPS Forecast
$0.20
2029 EPS Forecast
$0.22
2029 EPS Forecast
$0.22
2030 EPS Forecast
$0.23
2030 EPS Forecast
$0.23